Preetam Shah - 01 Sep 2021 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role
CFO & CBO
Signature
/s/ Preetam Shah
Issuer symbol
CDTX
Transactions as of
01 Sep 2021
Net transactions value
$0
Form type
4
Filing time
03 Sep 2021, 16:32:11 UTC
Next filing
15 Nov 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDTX Stock Option (right to buy) Award $0 +311,850 $0.000000 311,850 01 Sep 2021 Common Stock 311,850 $2.22 Direct F1
transaction CDTX Restricted Stock Unit Award $0 +50,000 $0.000000 50,000 01 Sep 2021 Common Stock 50,000 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date of September 1, 2021; 1/48th of the shares subject to the option shall vest monthly thereafter,such that all shares will be vested on September 1, 2025.
F2 Restricted stock units convert into common stock on a one-for-one basis.
F3 The RSU will fully vest upon the completion of certain corporate milestones on or before September 30, 2022.